Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Net Cash Flow (2022 - 2026)

Genelux (GNLX) posted Net Cash Flow of $3.9 million for Q1 2026, up 509.22% on a QoQ basis from $640000.0 in Q4 2025, and down 48.97% year-over-year from $7.6 million in Q1 2025.

Analysis

Genelux (GNLX) Net Cash Flow (2022 - 2026) Analysis & Trends

Genelux has reported Net Cash Flow for 5 years, with the latest figure at $3.9 million in Q1 2026.

  • On a quarterly basis, Net Cash Flow fell 48.97% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was -$7.0 million, a 157.69% decrease from a year earlier, with the FY2025 full-year figure at -$3.3 million, down 282.65% from the prior year.
  • Net Cash Flow was $3.9 million for Q1 2026 at Genelux, up from $640000.0 in the prior quarter.
  • The five-year high for Net Cash Flow was $16.8 million in Q2 2023, with the low at -$20.5 million in Q4 2023.
  • Average Net Cash Flow over 5 years is $700666.7, with a median of $2.5 million recorded in 2024.
  • The largest YoY upside for Net Cash Flow was 270.93% in 2023 against a maximum downside of 2001.85% in 2023.
  • Over 5 years, Net Cash Flow stood at -$973000.0 in 2022, then tumbled by 2001.85% to -$20.5 million in 2023, then soared by 112.04% to $2.5 million in 2024, then sank by 74.02% to $640000.0 in 2025, then surged by 509.22% to $3.9 million in 2026.
  • The last three Net Cash Flow figures came in at $3.9 million (Q1 2026), $640000.0 (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -496,000.00
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -170.75 Mn
10 Genelux 108.17 Mn 108.17 Mn - 3.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.90 Mn
Dec 31, 2025 640,000.00
Sep 30, 2025 -1.88 Mn
Jun 30, 2025 -9.67 Mn
Mar 31, 2025 7.64 Mn
Dec 31, 2024 2.46 Mn
Sep 30, 2024 -1.76 Mn
Jun 30, 2024 3.80 Mn
Mar 31, 2024 -5.36 Mn
Dec 31, 2023 -20.45 Mn
Sep 30, 2023 2.73 Mn
Jun 30, 2023 16.80 Mn
Mar 31, 2023 9.94 Mn
Dec 31, 2022 -973,000.00
Mar 31, 2022 2.68 Mn